16:09 EST Heron Therapeutics sees Q4 EBITDA, excluding stock compensation, ($10M)-($6M)
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on HRTX:
